Realheart's CEO to Present at the Swiss Nordic Bio Zürich Healthcare Investor Conference
Press Release, 29 March, 2023 Artificial hearts open the door to a paradigm shift in the care of patients with severe heart failure. Here, saving lives and reducing healthcare costs go hand in hand. There is an increased interest in the possibilities of total artificial hearts (TAH) and the interest in Realheart is much higher this year compared to last year's conference. Ina Laura Perkins will present the company at 12.00 on March 30, followed by several personal meetings with European medtech investors.For the second year in a row, Realheart is participating in Business Sweden's